Eugene Williams
Director at ProMIS Neurosciences Inc. (PMN)
Eugene Williams has filed 7 insider reports with the SEC since October 2024, as director at ProMIS Neurosciences Inc. (PMN). In the last 12 months Eugene Williams bought $237K of stock on the open market. In the latest amended filing, on November 6, 2026, Eugene Williams bought 26,500 shares of ProMIS Neurosciences Inc. (PMN) for $90.9K at an average of $3.43.
- Filings
- 7
- Companies
- 1
- Bought on market
- $237K
- Sold on market
- None
Companies where Eugene Williams is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | 40,213 | $237K | $7.02 | $3.29-53% | Nov 6, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Nov 4, 2026+$90.9KPMNDirector Williams Eugene bought $90,895 worth of shares (26,500 units at $3.43), increasing direct ownership by 193% to 40,213 unitsForm 4/AOpen-market purchase
- Oct 30, 2026+$5,251PMNDirector Williams Eugene bought $5,251 worth of shares (1,316 units at $3.99), increasing direct ownership by 11% to 13,713 unitsForm 4/AOpen-market purchase
- May 20, 2026PMNSEC Form 4 filed by Director Williams EugeneForm 4Grant or award
- Mar 5, 2026+$48.8KPMNDirector Williams Eugene bought $48,800 worth of shares (2,000 units at $24.40), increasing direct ownership by 19% to 12,397 unitsForm 4/AOpen-market purchase
- Mar 4, 2026+$92.4KPMNDirector Williams Eugene bought $92,420 worth of shares (4,000 units at $23.11), increasing direct ownership by 63% to 10,397 unitsForm 4/AOpen-market purchase
- Jun 12, 2025PMNSEC Form 4 filed by Director Williams EugeneForm 4Grant or award
- Oct 3, 2024PMNSEC Form 4 filed by Director Williams EugeneForm 4Grant or award
Compare Eugene Williams with
- Eugene Williams vs Neil Cashman1 shared
- Eugene Williams vs Johanne Kaplan1 shared
- Eugene Williams vs William W Wyman1 shared
- Eugene Williams vs Neil K Warma1 shared
- Eugene Williams vs Madge K. Shafmaster1 shared
- Eugene Williams vs Max A. Milbury1 shared
Other insiders at the same companies
- Neil CashmanPMN
- Johanne KaplanPMN
- William W WymanPMN
- Neil K WarmaPMN
- Madge K. ShafmasterPMN
- Max A. MilburyPMN
- Josh Mandel-BrehmPMN
- Slanix Paul AlexPMN
- Patrick D. KirwinPMN
- ABG V-SIV IX LtdPMN
- ABG Management Ltd.PMN
- Jeremy M. Sclar 2012 Irrevocable Family TrustPMN
- Larry Douglas AltstielPMN
- Jeremy M. SclarPMN
- Shaf QIC LLCPMN
- 19 Promis TitlePMN
Questions about Eugene Williams
- What is Eugene Williams's role at ProMIS Neurosciences Inc.?
- Eugene Williams reports to the SEC as director at ProMIS Neurosciences Inc. (PMN), according to the latest filing on November 6, 2026.
- How many shares does Eugene Williams own?
- After the latest filing that states it, Eugene Williams directly owned 40,213 shares of ProMIS Neurosciences Inc. (PMN). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Eugene Williams bought or sold stock recently?
- The most recent open-market purchase was on November 4, 2026: bought 26,500 shares of ProMIS Neurosciences Inc. (PMN) for $90.9K at an average of $3.43.
- How do I get alerts when Eugene Williams files?
- Follow Eugene Williams on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Eugene Williams filed 2 times in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Eugene Williams (SEC CIK 0001927626). Totals count each trade once, skipping amendments whose original is on file, from Oct 7, 2024 on. View on SEC EDGAR